Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Outer Biosciences
AddedFeb 17, 2024
UpdatedJun 18, 2026
Outer Biosciences

Outer Biosciences

Outer Biosciences: A stealth-mode biotech company.

HQ
Palo Alto, CA, US
Founded
2020
Overview
Compare
Fundraising
Employees
Website

Outer Biosciences, founded by a team of experienced scientists, is a stealth-mode biotech company focused on revolutionizing skin health. Their mission is to discover and develop novel bioactives that are more effective and safer than current options. Utilizing an advanced ex vivo discovery engine, they create complex, long-lasting, clinically-relevant skin models combined with multimodal data analysis and predictive capabilities to innovate in the skincare market.

Notable figures affiliated with Outer Biosciences include its founding scientific team, who bring extensive expertise in engineering advanced organ systems. While operating in stealth mode limits public disclosures, the company's integrated technology platform and innovative approach have positioned it as a potential leader in the biotech sector. Their breakthroughs in bioactives promise significant advancements in skin health, potentially impacting both consumer skincare products and medical dermatology treatments.

Outer Biosciences - Similar Companies

Montlake Bioscience logo

Montlake Bioscience

Omni Biosciences logo

Omni Biosciences

Outplay logo

Outplay

outplayinc.com

Fount Bio logo

Fount Bio

fountbio.com

OneSkin logo

OneSkin

Surf Bio logo

Surf Bio

surf.bio

RegenX Science logo

RegenX Science

regenxscience.com

Omix.ai logo

Omix.ai

PMGC Holdings logo

PMGC Holdings

Aobiome logo

Aobiome

aobiome.com

Outpace Bio logo

Outpace Bio

outpacebio.com

Omni Bioceutical Innovations logo

Omni Bioceutical Innovations

DermBiont logo

DermBiont

dermbiont.com

Advanced Biomedics logo

Advanced Biomedics

Marlinspike Therapeutics logo

Marlinspike Therapeutics

Outer Biosciences - Quick Facts

Who are Outer Biosciences' competitors?

Companies similar to Outer Biosciences include Montlake Bioscience, Omni Biosciences, Outplay and Fount Bio.

When was Outer Biosciences founded?

Outer Biosciences was founded in 2020.

Where is Outer Biosciences' headquarters located?

Outer Biosciences' headquarters is located in Palo Alto, CA, US.

When was Outer Biosciences' last funding round?

Outer Biosciences' most recent funding round was for $4M (USD) in April 2022.

How much has Outer Biosciences raised to-date?

As of Apr 7, 2022, Outer Biosciences has raised a total of $4M (USD).

How many employees does Outer Biosciences have?

Outer Biosciences has 5 employees as of Feb 5, 2024.

Outer Biosciences - Classification

Ownership
  • Private
  • Venture Capital
Technology
  • Biotech
Revenue
  • Recurring
Main Product
  • Biotech
  • Skincare
Tags
  • SaaS
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541500Computer Systems Design and Related Services
  • 541000Professional, Scientific, and Technical Services
  • 541510Computer Systems Design and Related Services
  • 541511Custom Computer Programming Services
SIC
  • 7300Business Services
  • 7370Computer Programming, Data Processing, And Other Computer Related
  • 7371Computer Programming Services
Show 5 more industry codes
NAICS
  • 513200Software Publishers
  • 510000Information
  • 513000Publishing Industries
  • 513210Software Publishers
SIC
  • 7372Prepackaged Software